How is the Cyclerion Therapeutics Inc today?

The Cyclerion Therapeutics Inc today is trading in the down by -6.40% at 3.07.

What is Cyclerion Therapeutics Inc Annual Net Profit?

Cyclerion Therapeutics Inc Annual Net Profit rose 41.92% in the last year to $3.06 M. Its sector's average net profit growth for the last fiscal year was -11.04%.

What is Cyclerion Therapeutics Inc Price to Earning Ratio?

Cyclerion Therapeutics Inc Price to Earning Ratio is -3.19, which is negative.

What is Cyclerion Therapeutics Inc Stock Price?

Cyclerion Therapeutics Inc Stock Price rose 9.64% and underperformed its sector by 1.69% in the past year.

What is Cyclerion Therapeutics Inc Quarterly Net profit?

Cyclerion Therapeutics Inc Quarterly Net profit rose 7.33% YoY to $1.43 M. Its sector's average net profit growth YoY for the quarter was -212.78%.

What is Cyclerion Therapeutics Inc Return on Equity(ROE)?

Cyclerion Therapeutics Inc Return on Equity(ROE) for the last financial year was -30.36%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Cyclerion Therapeutics Inc Mutual Fund Holding?

Cyclerion Therapeutics Inc Mutual Fund Holding increased by 0.1% in the last quarter to 3.96.

What is Cyclerion Therapeutics Inc Promoter Share Holding?

Cyclerion Therapeutics Inc Promoter Share Holding increased by 0.7% in the most recent quarter to 2.66%.

What is Cyclerion Therapeutics Inc Institutional Holding?

Cyclerion Therapeutics Inc Institutional Holding decreased by 0.5% in the last quarter to 12.96.

Cyclerion Therapeutics Inc XNAS: CYCN

Cyclerion Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Cyclerion Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Cyclerion Therapeutics Inc
Rating: 1.85958325
Author: Trendlyne DVM scores

about

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus i...

3.07 -0.21 (-6.40%)

63.63% Fall from 52W High

18,139 XNAS Volume

XNAS 21 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

19.3 / 100

Technically Neutral

55.1 / 100

No estimates available

Cyclerion Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cyclerion Therapeutics Inc FAQ

How is Cyclerion Therapeutics Inc today?

Cyclerion Therapeutics Inc today is trading in the red, and is down by -6.40% at 3.07.

How has Cyclerion Therapeutics Inc performed historically?

Cyclerion Therapeutics Inc is currently trading down -6.40% on an intraday basis. In the past week the stock fell -1.60%. stock has been up 13.28% in the past quarter and rose 9.64% in the past year. You can view this in the overview section.